source
- Compass Pathways leads race for first psychedelic drug approval, non-profit rivalsCompass Pathways is widely viewed as a leading candidate to bring the first psychedelic medicine to market. The company has advanced its therapy through clinical development and is positioned near…
- Midterm elections could reshape health policy, Medicare Advantage and insurance, STAT analysis saysSTAT's D.C. Diagnosis newsletter looks at how the upcoming midterm elections may influence health policy, Medicare Advantage programs and health insurance markets. With record early voting turnout…